Astellas Pharma Stock Forecast

Buy or Hold candidate since Jul 29, 2026 Loss -3.91%

The Astellas Pharma, Inc. stock price fell by -3.91% on the last day (Friday, 31st Jul 2026) from $15.35 to $14.75. During the last trading day the stock fluctuated 0% from a day low at $14.75 to a day high of $14.75. The price has been going up and down for this period, and there has been a 7.86% gain for the last 2 weeks. Volume has increased on the last day by 132 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 132 shares were bought and sold for approximately $1.95 thousand.

The stock lies the upper part of a wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $15.33 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -7.05% during the next 3 months and, with a 90% probability hold a price between $11.48 and $14.25 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

ALPMF Signals & Forecast

The Astellas Pharma, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $14.32 and $13.66. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 30, 2026, and so far it has fallen -3.91%. Further fall is indicated until a new bottom pivot has been found. Astellas Pharma, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Astellas Pharma, Inc. stock

Astellas Pharma, Inc. finds support from accumulated volume at $14.35 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week, the stock has had daily average volatility of 5.29%.

Our recommended stop-loss: $14.11 (-4.31%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (ALPMF) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Astellas Pharma, Inc. to open at $14.75, and during the day (based on 14 day Average True Range), to move between $14.35 and $15.15, which gives a possible trading interval of +/-$0.81 (+/-5.62%) up or down from last closing price. If Astellas Pharma, Inc. takes out the full calculated possible swing range there will be an estimated 5.62% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $14.96 (1.42%) than the support at $14.35 (2.71%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Dividend Warning For ALPMF

Dividend coming up for ALPMF: Ex-dividend date (Tuesday 29th September, 2026) is 59 days away. The dividend is $0.200.

Is Astellas Pharma, Inc. stock A Buy?

Astellas Pharma, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $14.75 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk